The past three years have seen tremendous breakthroughs in HIV prevention research. Since 2009, we have seen the first vaccine to show effectiveness, a microbicide that was found to be modestly efficacious and two studies demonstrating that an HIV medication could be used as a pre-exposure prophylaxis or could reduce new infections by treating those with HIV earlier. These advances have led many to herald a new era in our 30-year campaign to end the epidemic.
Developing bold, data-driven solutions to the world’s biggest challenges